Europe LDL Test Market – Industry Trends and Forecast to 2026

  • In Vitro Diagnostics
  • Publish Reports
  • Europe
  • 350 Pages
  • No of Tables: 23
  • No of Figures: 80
Europe LDL Test Market By Component (Kits & Reagents, Devices, Services), Disease (Diabetes, Stroke, Atherosclerosis, Obesity, Dyslipidaemia, Carotid Artery Disease, Peripheral Arterial Disease, Angina, Others), Distribution Channel (Direct Tenders, Retail), End User (Hospitals, Clinics, Ambulatory Care, Research Laboratory), Country (Germany, U.K., France, Italy, Spain, Switzerland, Netherlands, Russia, Belgium, Turkey, Rest of Europe) – Industry Trends and Forecast to 2026 Low density lipoprotein (LDL) is known as bad cholesterol because it is build-up of extra fat in arteries. This condition narrows the arteries and raises the risk of heart attack, stroke and peripheral artery disease. So for the determination of LDL, various kits, reagent and devices are used. For instance N-geneous LDL cholesterol calibrator which used as LDL test for determination of low density lipoprotein for measuring risk of heart diseases. It is basically for in-vitro diagnostic use. These circular particles serve to solubilize and transport cholesterol and triglyceride in the blood stream. The relative proportions of protein and lipid calculates the density of this lipoprotein. The test LDL cholesterol acts as a key factor for determine pathogenesis of atherosclerosis and coronary heart disease. By the use of this test can easily find out associated risk for heart diseases. Europe LDL test market is projected to register a significant CAGR in the forecast period of 2019 to 2026.

Segmentation: Europe LDL Test Market

Europe LDL test market is segmented into four notable segments such as component, disease, end user, distribution channel.
  • On the basis of component, the market is segmented into devices, kits & reagents and services..
  • In March 2019, Merck KGAA (Germany) expands manufacturing facilities for biotech medicines in Aubonne, Switzerland. With this expansion the Company has expanded its manufacturing capacity for biotech medicines.
  • On the basis of disease, the market is segmented into atherosclerosis, obesity, dyslipidemia, diabetes, angina, stroke, carotid artery disease, peripheral arterial disease, others.
  • On the basis of distribution channel, the market is segmented into direct tenders and retail.
  • On the basis of end user, the market is segmented into hospitals, clinics, research laboratory, and ambulatory care.

Competitive Analysis: Europe LDL Test Market

Some of the major players operating in this market are Quest Diagnostics, Sekisui Diagnostics, Express Biotech International, Randox Laboratories Ltd, Reckondiagnostics, Diasys Diagnostic Systems GmbH, F. Hoffmann-La Roche Ltd, Abbott, Eurolyser Diagnostica GmbH, Sigma-Aldrich, Diazyme Laboratories, Inc., Laboratory Corporation of America, Cell Biolabs, Inc., Atlas Medical U.K, Eurofins Scientific, Thermo Fisher Scientific Inc., Home Access Health and others. Product Launch
  • In February 2019 Randox Laboratories Ltd (U.K) launched a new website which provides information about the products. By this website potential customers can identify their product related information. This website launch is helpful in increasing the business awareness by providing easy way of learning about the company’s products and services.

Research Methodology: Europe LDL Test Market

Primary Respondents: Key Opinion Leaders (KOL’s): Manufacturer, Healthcare Professionals, Doctors, Nurses, Medical practitioners. Industry Participants: CEO’s, V.P.’s, Marketing/Product Managers, Market Intelligence Managers and, National Sales Managers.

TABLE OF CONTENTS EUROPE LDL TEST MARKET

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY 1.2 MARKET DEFINITION 1.3 OVERVIEW OF EUROPE LDL TEST MARKET 1.4 CURRENCY AND PRICING 1.5 LIMITATIONS 1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED 2.2 EUROPE LDL TEST MARKET: GEOGRAPHICAL SCOPE 2.3 YEARS CONSIDERED FOR THE STUDY 2.4 CURRENCY AND PRICING 2.5 RESEARCH METHODOLOGY 2.6 DBMR MARKET POSITION GRID 2.7 DBMR MARKET CHALLENGE MATRIX 2.8 DBMR VENDOR SHARE ANALYSIS 2.9 MULTIVARIATE MODELING 2.10 PRODUCTS LIFELINE CURVE 2.11 KEY PRIMARY INSIGHTS 2.12 SECONDARY SOURCES 2.13 ASSUMPTIONS

3 MARKET OVERVIEW

3.1 DRIVERS

3.1.1 RISING AWARENESS AMONG PATIENT 3.1.2 INCREASING PREVALENCE OF CARDIOVASCULAR DISEASES AND OBESITY 3.1.3 INCREASING NUMBER OF GERIATRIC PEOPLE 3.1.4 GOVERNMENT INITIATIVES TO IMPROVE QUALITY OF TESTING

3.2 RESTRAINTS

3.2.1 RISKS ASSOCIATED WITH TESTS LIKE BLEEDING AND INFECTION 3.2.2 EMERGENCE OF NON-INVASIVE CHOLESTEROL TESTING METHODS

3.3 OPPORTUNITIES

3.3.1 HIGH GROWTH POSSIBILITY IN LDL TEST IN DEVELOPING COUNTRIES 3.3.2 PATIENT-INITIATED TESTING

3.4 CHALLENGES

3.4.1 PATIENT DATA SECURITY 3.4.2 EVOLVING REGULATORY POLICIES

4 EXECUTIVE SUMMARY 5 PREMIUM INSIGHTS 6 EUROPE LDL TEST MARKET, BY COMPONENTS

6.1 OVERVIEW 6.2 KITS & REAGENTS 6.3 DEVICES

6.3.1 SPECTROPHOTOMETER 6.3.2 SYRINGES AND NEEDLES 6.3.3 OTHERS

6.4 SERVICES

7 EUROPE LDL TESTING MARKET, BY DISEASE

7.1 OVERVIEW 7.2 DIABETES 7.3 STROKE 7.4 ATHEROSCLEROSIS 7.5 OBESITY 7.6 DYSLIPIDEMIA 7.7 CAROTID ARTERY DISEASE 7.8 PERIPHERAL ARTERIAL DISEASE 7.9 ANGINA 7.10 OTHERS

8 EUROPE LDL TEST MARKET, BY DISTRIBUTION CHANNEL

8.1 OVERVIEW 8.2 DIRECT TENDERS 8.3 RETAIL

9 EUROPE LDL TEST MARKET, BY END USER

9.1 OVERVIEW 9.2 HOSPITALS 9.3 CLINICS 9.4 AMBULATORY CARE 9.5 RESEARCH LABORATORY

10 EUROPE LDL TEST MARKET, BY GEOGRAPHY

10.1 EUROPE

10.1.1 GERMANY 10.1.2 U.K 10.1.3 FRANCE 10.1.4 ITALY 10.1.5 SPAIN 10.1.6 SWITZERLAND 10.1.7 NETHERLANDS 10.1.8 RUSSIA 10.1.9 BELGIUM 10.1.10 TURKEY 10.1.11 REST OF EUROPE

11 EUROPE LDL TEST MARKET, COMPANY LANDSCAPE

11.1 COMPANY SHARE ANALYSIS: EUROPE

12 SWOT ANALYSIS

12.1 STRENGTH 12.2 WEAKNESS 12.3 OPPORTUNITY 12.4 THREAT 12.5 DATA BRIDGE MARKET RESEARCH ANALYSIS

13 COMPANY PROFILE

13.1 F. HOFFMANN-LA ROCHE LTD

13.1.1 COMPANY SNAPSHOT 13.1.2 REVENUE ANALYSIS 13.1.3 COMPANY SHARE ANALYSIS 13.1.4 GEOGRAPHICAL PRESENCE 13.1.5 PRODUCT PORTFOLIO 13.1.6 RECENT DEVELOPMENTS

13.2 MERCK KGAA

13.2.1 COMPANY SNAPSHOT 13.2.2 REVENUE ANALYSIS 13.2.3 COMPANY SHARE ANALYSIS 13.2.4 GEOGRAPHICAL PRESENCE 13.2.5 PRODUCT PORTFOLIO 13.2.6 RECENT DEVELOPMENT

13.3 ABBOTT

13.3.1 COMPANY SNAPSHOT 13.3.2 REVENUE ANALYSIS 13.3.3 COMPANY SHARE ANALYSIS 13.3.4 GEOGRAPHICAL PRESENCE 13.3.5 PRODUCT PORTFOLIO 13.3.6 RECENT DEVELOPMENTS

13.4 SEKISUI DIAGNOSTICS

13.4.1 COMPANY SNAPSHOT 13.4.2 COMPANY SHARE ANALYSIS 13.4.3 GEOGRAPHICAL PRESENCE 13.4.4 PRODUCT PORTFOLIO 13.4.5 RECENT DEVELOPMENT

13.5 ATLAS MEDICAL U.K

13.5.1 COMPANY SNAPSHOT 13.5.2 GEOGRAPHICAL PRESENCE 13.5.3 PRODUCT PORTFOLIO 13.5.4 RECENT DEVELOPMENTS

13.6 CELL BIOLABS, INC

13.6.1 COMPANY SNAPSHOT 13.6.2 GEOGRAPHICAL PRESENCE 13.6.3 PRODUCT PORTFOLIO 13.6.4 RECENT DEVELOPMENTS

13.7 DIASYS DIAGNOSTIC SYSTEMS GMBH

13.7.1 COMPANY SNAPSHOT 13.7.2 GEOGRAPHICAL PRESENCE 13.7.3 PRODUCT PORTFOLIO 13.7.4 RECENT DEVELOPMENT

13.8 DIAZYME LABORATORIES, INC

13.8.1 COMPANY SNAPSHOT 13.8.2 GEOGRAPHICAL PRESENCE 13.8.3 PRODUCT PORTFOLIO 13.8.4 RECENT DEVELOPMENTS

13.9 EUROFINS SCIENTIFIC

13.9.1 COMPANY SNAPSHOT 13.9.2 REVENUE ANALYSIS 13.9.3 GEOGRAPHICAL PRESENCE 13.9.4 PRODUCT PORTFOLIO 13.9.5 RECENT DEVELOPMENT

13.10 EUROLYSER DIAGNOSTICA GMBH

13.10.1 COMPANY SNAPSHOT 13.10.2 GEOGRAPHICAL PRESENCE 13.10.3 PRODUCT PORTFOLIO 13.10.4 RECENT DEVELOPMENTS

13.11 EXPRESS BIOTECH INTERNATIONAL

13.11.1 COMPANY SNAPSHOT 13.11.2 GEOGRAPHICAL PRESENCE 13.11.3 PRODUCT PORTFOLIO 13.11.4 RECENT DEVELOPMENTS

13.12 HOME ACCESS HEALTH

13.12.1 COMPANY SNAPSHOT 13.12.2 PRODUCT PORTFOLIO 13.12.3 RECENT DEVELOPMENTS

13.13 LABORATORY CORPORATION OF AMERICA

13.13.1 COMPANY SNAPSHOT 13.13.2 REVENUE ANALYSIS 13.13.3 GEOGRAPHICAL PRESENCE 13.13.4 PRODUCT PORTFOLIO 13.13.5 RECENT DEVELOPMENTS

13.14 QUEST DIAGNOSTICS

13.14.1 COMPANY SNAPSHOT 13.14.2 REVENUE ANALYSIS 13.14.3 GEOGRAPHICAL PRESENCE 13.14.4 PRODUCT PORTFOLIO 13.14.5 RECENT DEVELOPMENT

13.15 RANDOX LABORATORIES LTD

13.15.1 COMPANY SNAPSHOT 13.15.2 GEOGRAPHICAL PRESENCE 13.15.3 PRODUCT PORTFOLIO 13.15.4 RECENT DEVELOPMENT

13.16 RECKONDIAGNOSTICS

13.16.1 COMPANY SNAPSHOT 13.16.2 PRODUCT PORTFOLIO 13.16.3 RECENT DEVELOPMENTS

13.17 THERMO FISHER SCIENTIFIC INC

13.17.1 COMPANY SNAPSHOT 13.17.2 REVENUE ANALYSIS 13.17.3 GEOGRAPHICAL PRESENCE 13.17.4 PRODUCT PORTFOLIO 13.17.5 RECENT DEVELOPMENTS

14 CONCLUSION 15 QUESTIONNAIRE 16 RELATED REPORTS
 

LIST OF TABLES EUROPE LDL TEST MARKET

TABLE 1 EUROPE LDL TEST MARKET, BY COMPONENTS, 2017– 2026 (USD MILLION) TABLE 2 EUROPE KITS & REAGENTS IN EUROPE LDL TEST MARKET BY REGION, 2017-2026, USD MILLION TABLE 3 EUROPE DEVICES IN LDL TEST MARKET, BY COMPONENT, 2017-2026, USD MILLION TABLE 4 EUROPE DEVICES IN LDL TEST MARKET, BY REGION, 2017-2026, USD MILLION TABLE 5 EUROPE SERVICES IN EUROPE LDL TEST MARKET BY REGION, 2017-2026, USD MILLION TABLE 6 EUROPE LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION) TABLE 7 EUROPE DIABETES IN LDL TEST MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 8 EUROPE STROKE IN LDL TEST MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 9 EUROPE ATHEROSCLEROSIS IN LDL TEST MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 10 EUROPE OBESITY IN LDL TEST MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 11 EUROPE DYSLIPIDEMIA IN LDL TEST MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 12 EUROPE CAROTID ARTERY DISEASE IN LDL TEST MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 13 EUROPE PERIPHERAL ARTERIAL DISEASES IN LDL TEST MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 14 EUROPE ANGINA IN LDL TEST MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 15 EUROPE OTHERS IN LDL TEST MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 16 EUROPE LDL TEST MARKET, BY DRISTIBUTION CHANNEL, 2017– 2026 (USD MILLION) TABLE 17 EUROPE DIRECT TENTERS IN EUROPE LDL TEST MARKET, BY REGION, 2017-2026, USD MILLION TABLE 18 EUROPE RETAIL IN EUROPE LDL TEST MARKET, BY REGION, 2017-2026, USD MILLION TABLE 19 EUROPE LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 20 EUROPE HOSPITALS IN LDL TEST MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 21 EUROPE CLINICS IN LDL TEST MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 22 EUROPE AMBULATORY CARE IN LDL TEST MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 23 EUROPE RESEARCH LABORATORY IN LDL TEST MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 24 EUROPE LDL TEST MARKET, BY REGION, 2017-2026 (USD MILLION) TABLE 25 EUROPE LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 26 EUROPE DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 27 EUROPE LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION) TABLE 28 EUROPE LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 29 EUROPE LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 30 GERMANY LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 31 GERMANY DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 32 GERMANY LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION) TABLE 33 GERMANY LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 34 GERMANY LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 35 U.K LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 36 U.K DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 37 U.K LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION) TABLE 38 U.K LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 39 U.K LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 40 FRANCE LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 41 FRANCE DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 42 FRANCE LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION) TABLE 43 FRANCE LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 44 FRANCE LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 45 ITALY LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 46 ITALY DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 47 ITALY LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION) TABLE 48 ITALY LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 49 ITALY LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 50 SPAIN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 51 SPAIN DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 52 SPAIN LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION) TABLE 53 SPAIN LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 54 SPAIN LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 55 SWITZERLAND LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 56 SWITZERLAND DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 57 SWITZERLAND LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION) TABLE 58 SWITZERLAND LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 59 SWITZERLAND LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 60 NETHERLANDS LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 61 NETHERLANDS DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 62 NETHERLANDS LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION) TABLE 63 NETHERLANDS LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 64 NETHERLANDS LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 65 RUSSIA LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 66 RUSSIA DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 67 RUSSIA LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION) TABLE 68 RUSSIA LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 69 RUSSIA LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 70 BELGIUM LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 71 BELGIUM DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 72 BELGIUM LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION) TABLE 73 BELGIUM LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 74 BELGIUM LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 75 TURKEY LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 76 TURKEY DEVICES IN LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION) TABLE 77 TURKEY LDL TEST MARKET, BY DISEASE, 2017-2026 (USD MILLION) TABLE 78 TURKEY LDL TEST MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION) TABLE 79 TURKEY LDL TEST MARKET, BY END USER, 2017-2026 (USD MILLION) TABLE 80 REST OF EUROPE LDL TEST MARKET, BY COMPONENTS, 2017-2026 (USD MILLION)
 

LIST OF FIGURES EUROPE LDL TEST MARKET

FIGURE 1 EUROPE LDL TEST MARKET: SEGMENTATION FIGURE 2 EUROPE LDL TEST MARKET: DATA TRIANGULATION FIGURE 3 EUROPE LDL TEST MARKET: DROC ANALYSIS FIGURE 4 EUROPE LDL TEST MARKET: EUROPE VS REGIONAL MARKET ANALYSIS FIGURE 5 EUROPE LDL TEST MARKET: COMPANY RESEARCH ANALYSIS FIGURE 6 EUROPE LDL TEST MARKET: INTERVIEW DEMOGRAPHICS FIGURE 7 EUROPE LDL TEST MARKET: DBMR MARKET POSITION GRID FIGURE 8 EUROPE LDL TEST MARKET: THE MARKET CHALLENGE MATRIX FIGURE 9 EUROPE LDL TEST MARKET: DBMR VENDOR SHARE ANALYSIS FIGURE 10 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE EUROPE LDL TEST MARKET FIGURE 11 EUROPE LDL TEST MARKET: SEGMENTATION FIGURE 12 INCREASING GERIATRIC POPULATION, INCREASING OBESITY AND OVERWEIGHT POPULATION ARE EXPECTED TO DRIVE THE EUROPE LDL TEST MARKET IN THE FORECAST PERIOD OF 2019 TO 2026 FIGURE 13 KITS AND REAGENTS IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE LDL TEST MARKET IN 2019 & 2026 FIGURE 14 EUROPE LDL TEST MARKET: BY COMPONENT, 2018 FIGURE 15 EUROPE LDL TESTING MARKET: BY DISEASE, 2018 FIGURE 16 EUROPE LDL MARKET: BY DISTRIBUTION CHANNEL, 2018 FIGURE 17 EUROPE LDL TEST MARKET: BY END USER, 2018 FIGURE 18 EUROPE LDL TEST MARKET: SNAPSHOT (2018) FIGURE 19 EUROPE LDL TEST MARKET: BY COUNTRY (2018) FIGURE 20 EUROPE LDL TEST MARKET: BY COUNTRY (2019 & 2026) FIGURE 21 EUROPE LDL TEST MARKET: BY COUNTRY (2018 & 2026) FIGURE 22 EUROPE LDL TEST MARKET: BY COMPONENTS (2019-2026) FIGURE 23 EUROPE LDL TEST MARKET: COMPANY SHARE 2018 (%)

Please fill in the below form for detailed Inquire Before Buying

Choose License Type
  • $3200.00
  • $2500.00
BUY NOW ADD TO CART